A Paradigm Shift in First-Line Treatment Can Have Many Implications For Second-Line Treatment

J Thorac Oncol. 2024 Feb;19(2):350. doi: 10.1016/j.jtho.2023.11.006.

Author

Tadashi Nishimura¹

Affiliation

¹ Department of Pulmonary Medicine, Mie Chuo Medical Center Mie, Japan; Department of Pulmonary and Critical Care Medicine, Mie University Graduate School of Medicine, Mie, Japan. Electronic address: shidatafireflash@gmail.com.

PMID: 38325986
DOI: 10.1016/j.jtho.2023.11.006

No abstract available

Publication types

Letter
Comment